2型糖尿病表型、疾病进展与药物反应的异质性
研究对23137例新诊断糖尿病苏格兰患者常规数据应用反向图嵌入方法可视化表型异质性,并用分区糖尿病多基因风险评分探讨潜在生物学过程。叠加胰岛素需求、慢性肾脏病、需转诊糖尿病视网膜病变和主要不良心血管事件进展风险,显示不同表型患者风险各异,如视网膜病变风险患者与心血管事件风险患者表型不同。结果在英国生物银行和ADOPT临床试验中重复验证,并显示不同糖尿病药物单药治疗反应模式不同。
要点
- 视网膜病变风险患者与心血管事件风险患者表型不同。
- 不同糖尿病药物单药治疗反应模式存在差异。
- 表型变异驱动2型糖尿病发病并影响结局与药物反应。
核心结论
- 在欧洲人群中,潜在表型变异驱动2型糖尿病发病并影响后续糖尿病结局和药物反应,表明需将这些因素纳入2型糖尿病管理的个体化治疗。
研究设计与样本
- 对23137例新诊断糖尿病苏格兰患者常规收集数据应用反向图嵌入方法,并使用分区糖尿病多基因风险评分。
- 结果在英国生物银行和ADOPT临床试验中重复验证。
主要发现
- 叠加胰岛素需求、慢性肾脏病、需转诊糖尿病视网膜病变和主要不良心血管事件进展风险,显示这些风险因患者表型而异。
- 视网膜病变风险患者与心血管事件风险患者表型不同。
- 不同糖尿病药物单药治疗反应模式不同。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type 2 diabetes (T2D) is a complex chronic disease characterized by considerable phenotypic heterogeneity. In this study, we applied a reverse graph embedding method to routinely collected data from 23,137 Scottish patients with newly diagnosed diabetes to visualize this heterogeneity and used partitioned diabetes polygenic risk scores to gain insight into the underlying biological processes. Overlaying risk of progression to outcomes of insulin requirement, chronic kidney disease, referable diabetic retinopathy and major adverse cardiovascular events, we show how these risks differ by patient phenotype. For example, patients at risk of retinopathy are phenotypically different from those at risk of cardiovascular events. We replicated our findings in the UK Biobank and the ADOPT clinical trial, also showing that the pattern of diabetes drug monotherapy response differs for different drugs. Overall, our analysis highlights how, in a European population, underlying phenotypic variation drives T2D onset and affects subsequent diabetes outcomes and drug response, demonstrating the need to incorporate these factors into personalized treatment approaches for the management of T2D.
引用
- Nair ATN, Wesolowska-Andersen A, Brorsson C, et al. Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes. Nat Med. 2022. PMID: 35534565. doi:10.1038/s41591-022-01790-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。